Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment

Detalles Bibliográficos
Autores principales: Yalcin, Arzu Didem, Bisgin, Atil, Gorczynski, Reginald M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: World Allergy Organization 2013
Materias:
Meeting Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643731/
http://dx.doi.org/10.1186/1939-4551-6-S1-P221
_version_ 1782268364792528896
author Yalcin, Arzu Didem
Bisgin, Atil
Gorczynski, Reginald M
author_facet Yalcin, Arzu Didem
Bisgin, Atil
Gorczynski, Reginald M
author_sort Yalcin, Arzu Didem
collection PubMed
description
format Online
Article
Text
id pubmed-3643731
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher World Allergy Organization
record_format MEDLINE/PubMed
spelling pubmed-36437312013-05-08 Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment Yalcin, Arzu Didem Bisgin, Atil Gorczynski, Reginald M World Allergy Organ J Meeting Abstract World Allergy Organization 2013-04-23 /pmc/articles/PMC3643731/ http://dx.doi.org/10.1186/1939-4551-6-S1-P221 Text en Copyright ©2013 Yalcin et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Yalcin, Arzu Didem
Bisgin, Atil
Gorczynski, Reginald M
Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
title Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
title_full Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
title_fullStr Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
title_full_unstemmed Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
title_short Health outcomes, education, healthcare delivery and quality – 3052. IL-17, IL-18, TGF-beta and GMCSF levels in patients with allergic asthma: Its relation to omalizumab treatment
title_sort health outcomes, education, healthcare delivery and quality – 3052. il-17, il-18, tgf-beta and gmcsf levels in patients with allergic asthma: its relation to omalizumab treatment
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3643731/
http://dx.doi.org/10.1186/1939-4551-6-S1-P221
work_keys_str_mv AT yalcinarzudidem healthoutcomeseducationhealthcaredeliveryandquality3052il17il18tgfbetaandgmcsflevelsinpatientswithallergicasthmaitsrelationtoomalizumabtreatment
AT bisginatil healthoutcomeseducationhealthcaredeliveryandquality3052il17il18tgfbetaandgmcsflevelsinpatientswithallergicasthmaitsrelationtoomalizumabtreatment
AT gorczynskireginaldm healthoutcomeseducationhealthcaredeliveryandquality3052il17il18tgfbetaandgmcsflevelsinpatientswithallergicasthmaitsrelationtoomalizumabtreatment

Ejemplares similares